• Seaweed is recognized for its rich source of novel and promising lead biomolecules, particularly in brown seaweeds. • Secondary metabolites from seaweed have gained prominence over conventional synthetic active ingredients in drug discovery and pharmacotherapeutics. • Seaweed polysaccharides exhibit diverse biological activities, including anticancer, antioxidant, antiviral, antidiabetic, and antibacterial effects. • Polysaccharides from seaweeds like alginic acid, fucoidans, laminarians, and carrageenans are widely used in formulating pharmaceutical dosage forms. • Ethanolic extracts of S. marginatum exhibit cytotoxic activity, with promising results against cancer cell lines, including choriocarcinoma. • S. marginatum emerges as a promising source of biomedical secondary metabolites for future research, particularly in developing novel therapies for oral squamous cell carcinoma.
No takes yet. Share an insight, caveat, or question.
Balasubramanian et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: